Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04019613 · ClinicalTrials.gov registry record · NA

Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress Testing

A NA study, sponsored by Mayo Clinic.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT04019613: Clinical Trial NA study, sponsored by Mayo Clinic.

NCT04019613 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04019613, a NA study, was terminated before completion, sponsored by Mayo Clinic.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

The aim of this study is to utilize lung ultrasound to detect the development of extravascular lung water in patients undergoing clinically indicated invasive hemodynamic exercise stress testing for symptomatic shortness of breath. The study will correlate the lung ultrasound findings with cardiac hemodynamics and measurements of extravascular lung water in an effort to better understand the pathophysiology of exertional dyspnea.

Interventions

  • DIAGNOSTIC_TEST Lung ultrasound

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2019-11-08
Est. Completion 2019-12-19
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04019613

The ClinicalTrials.gov registry entry for NCT04019613 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Lung ultrasound is the first listed.

NCT04019613 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04019613 about?

NCT04019613 is a clinical study titled "Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress Testing". The aim of this study is to utilize lung ultrasound to detect the development of extravascular lung water in patients undergoing clinically indicated invasive hemodynamic exercise stress testing for symptomatic shortness of breath. The study will correlate the lung ultrasound findings with cardiac h...

What is the current status of trial NCT04019613?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2019-11-08. Estimated completion is 2019-12-19.

What interventions are being tested in trial NCT04019613?

The interventions under investigation include: Lung ultrasound (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04019613?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.